Barbara Blodi

About

Barbara Blodi, MD, MALD, is the Matthew D. Davis Professor at the University of Wisconsin–Madison, where she also serves as the Medical Director of the Wisconsin Reading Center. Her medical and surgical interests focus on retina, macula, and vitreous diseases, including age-related macular degeneration, diabetic retinopathy, posterior uveitis, retinal diseases, and vein occlusion. She is involved in research related to adaptive optics, analysis of new retinal imaging modalities such as ultra-widefield retinal imaging and OCT-angiography, artificial intelligence, and telemedicine. Dr. Blodi completed her fellowships in Medical Retina at the Bascom Palmer Eye Institute in Miami, FL, and Surgical Retina at the University of Michigan Kellogg Eye Center. She completed her residency at Bascom Palmer Eye Institute and her internship at Good Samaritan Medical Center in Phoenix, AZ. She earned her medical degree from the University of Iowa Carver College of Medicine. Her approach emphasizes listening to patients, providing comprehensive information and guidance about treatment options, and understanding that retinal treatment is often an incremental process requiring multiple visits.

Research topics

• Medicine
• Internal medicine
• Ophthalmology
• Surgery
• Computer Science
• Political Science
• Artificial Intelligence
• Law
• Endocrinology
• Engineering

Selected publications

• Foundational Considerations for Artificial Intelligence Using Ophthalmic Images

  Ophthalmology · 2021 · 90 citations

  PublisherOA PDFDOI

• Lapses in Care Among Patients Assigned to Ranibizumab for Proliferative Diabetic Retinopathy

  JAMA Ophthalmology · 2021 · 32 citations

  IMPORTANCE: The follow-up schedule for individuals with eyes treated with anti-vascular endothelial growth factor agents for proliferative diabetic retinopathy (PDR) requires that patients return frequently for monitoring and repeated treatment. The likelihood that a patient will comply should be a consideration in choosing a treatment approach. OBJECTIVE: To describe completion of scheduled examinations among participants assigned to intravitreous injections of ranibizumab for PDR in a multicen…

  DOI

• Risk Factors for the Development of Retinopathy in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Experience

  Diabetes Care · 2022 · 29 citations

  OBJECTIVE: To determine glycemic and nonglycemic risk factors that contribute to the presence of diabetic retinopathy (DR) before and after the onset of type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS: During the Diabetes Prevention Program (DPP) and DPP Outcome Study (DPPOS), we performed fundus photography over time in adults at high risk for developing T2D, including after they developed diabetes. Fundus photographs were graded using the Early Treatment Diabetic Retinopathy Study (ETDRS) g…

  PublisherOA PDFDOI

• Predominantly Persistent Intraretinal Fluid in the Comparison of Age-related Macular Degeneration Treatments Trials

  Ophthalmology Retina · 2022 · 22 citations

  PublisherOA PDFDOI

• Anatomic Biomarkers of Macular Edema Associated with Retinal Vein Occlusion

  Ophthalmology Retina · 2022-06-30 · 19 citations

  articleOpen accessSenior author
  PublisherOA PDFDOI

Frequent coauthors

• Amitha Domalpally

  University of Wisconsin–Madison

  60 shared

• Emily Y. Chew

  National Eye Institute

  46 shared

• Ronald J. Prineas

  42 shared

• Andrea M. Kriska

  38 shared

• Elizabeth M. Venditti

  University of Pittsburgh

  38 shared

• William C. Knowler

  37 shared

• Linda Semler

  36 shared

• Amer Rassam

  36 shared

Awards & honors

• Daniel M. Albert Chair, McPherson Eye Research Institute

Similar researchers at University of Wisconsin-Madison

• Shaoqin (Sarah) Gongh-96
• Daniel Alberth-70
• David Gammh-57